A Validated Automated THC Serum Method Still Had a Postmortem Limitation

A successful cannabinoid method validation does not establish suitability for every specimen. Researchers who developed an automated serum assay explicitly reported that postmortem samples could form a gel during extraction that the standard centrifugation procedure could not reliably separate.

What the automated method measured

The GC–MS workflow measured THC, 11-hydroxy-THC and free, unconjugated THC-COOH from 0.5 mL of serum. A robotic system handled extraction, phase separation, evaporation and derivatization-related steps, following initial sample and internal-standard preparation.

The authors compared manual and automated approaches using authentic forensic specimens and external controls. Both met the reported validation requirements, and the automated method successfully completed an external proficiency exercise.

The specimen problem occurred before chemical detection

Automation relies on predictable transfer of liquid between phases. Gel formation can disrupt that physical process, so a highly sensitive mass spectrometer cannot compensate simply by detecting smaller amounts.

The postmortem limitation concerned this particular automated workflow. It did not establish that all postmortem cannabinoid analysis is impossible, nor that every such specimen forms a gel. Another suitably validated preparation may address a specimen that this procedure cannot process reliably.

Agreement also varied across analytes

The manual–automated comparison used 20 real samples, although not every analyte was quantifiable in every sample. THC and THC-COOH results agreed more closely than 11-hydroxy-THC results, whose comparison showed greater deviations in the lower concentration range.

The method also checked carryover and potential interferences under defined conditions. Negative findings in those experiments support the tested workflow; they do not erase a separately identified specimen-handling limitation.

What to ask about an actual postmortem result

Identify the actual matrix, preparation method and validation scope. Ask whether unusual consistency, incomplete phase separation or other extraction problems were recorded, and how affected samples were handled.

Serum from living persons, postmortem serum and whole blood should not be treated as one interchangeable material. Nor does analytical validation itself establish that a measured concentration caused death or impairment. This paper illustrates why a method can perform well within its validated scope while requiring a different approach for a difficult specimen.

Related: Interpreting THC concentration and impairment.

Primary research

Development and validation of an automated liquid-liquid extraction GC/MS method for the determination of THC, 11-OH-THC, and free THC-carboxylic acid (THC-COOH) from blood serum. DOI: 10.1007/s00216-016-9537-5.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Next-Morning Cannabis Driving Study Found No Significant Group Deficit After Correction

Frequent cannabis users tested approximately 12–15 hours after smoking did not show a significant simulator-driving deficit relative to matched controls after correction for multiple comparisons. This observational finding does not establish a universal waiting period or prove that every participant was unimpaired. A next-morning group comparison The study compared 65…

Spread the love

Read Article: A Next-Morning Cannabis Driving Study Found No Significant Group Deficit After Correction

Statistical Adjustment Did Not Isolate CBD’s Effect in a Naturalistic Memory Study

A naturalistic study found different recognition-memory changes in THC-dominant and THC-plus-CBD product groups, including after statistical adjustment for a THC-related exposure measure. That adjustment did not independently isolate CBD as the cause of the difference. The product groups differed in more than CBD Thirty-two regular cannabis users underwent a brief…

Spread the love

Read Article: Statistical Adjustment Did Not Isolate CBD’s Effect in a Naturalistic Memory Study

A Capillary THC Study Obtained Acceptable Samples in 77% of Collection Attempts

A capillary cannabinoid study obtained acceptable specimens in 148 of 192 collection attempts, or 77%. That collection-success denominator matters alongside the chemical assay’s accuracy: a convenient device cannot provide a usable result when collection fails. Which collection method was actually evaluated? Twenty-nine adults used their own cannabis products under a…

Spread the love

Read Article: A Capillary THC Study Obtained Acceptable Samples in 77% of Collection Attempts

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us